查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1495999

治疗雷射全球市场 - 2024 年至 2029 年预测

Global Therapeutic Laser Market - Forecasts from 2024 to 2029
出版日期: | 出版商: Knowledge Sourcing Intelligence | 英文 134 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

治疗雷射市场预计将从 2022 年的 1,258.05 亿美元增至 2029 年的 2,370.22 亿美元，预测期内复合年增长率为 9.47%。

雷射治疗系统是一种无药物、非侵入性的治疗方法，可以缓解慢性和急性疼痛，同时改善血液循环。这些设备采用雷射脉衝穿透皮肤，不会造成发热、伤害或其他负面影响。雷射治疗系统可加速创伤治疗并减少软组织发炎和不适。这种雷射治疗被定位为标准药物和手术治疗的替代方案（如果不是辅助的话）。这些雷射系统透过解决疾病的根本原因提供长期的治疗效果。

治疗激光，也称为低强度激光或冷激光，是医疗设备。它用于多种医疗应用，包括疼痛管理、创伤治疗和组织修復。该市场包括不同类型的治疗雷射器，例如二极管雷射、染料雷射和 CO2 雷射。治疗性雷射广泛应用于缓解疼痛、创伤治疗、皮肤科和牙科。该市场的主要市场参与企业包括成熟的医疗设备公司和新兴市场参与企业。

FDA 和 EMA 等卫生当局的监管核准对于进入市场至关重要。阻碍因素包括提供者和患者对雷射治疗的好处和报销问题的认识有限。未来的趋势包括与其他技术、家用设备的整合以及正在进行的研究和临床试验。由于意识的提高、技术的进步以及对非侵入性治疗方案的需求不断增长，治疗雷射市场预计将在全球范围内扩张。

市场驱动因素：

  • 预计癌症发生率的增加将推动全球对治疗雷射的需求。

由于全球癌症发病率上升、手术数量增加以及自我护理和自我管理意识的增强，对治疗雷射的需求正在增加。此外，可支配收入的增加、医疗保健支出的增加和住院时间的缩短将在预计的十年及更长时间内推动全球治疗雷射市场的发展。

此外，多家公司已主动推出创新新产品，推动了预测期内的市场成长。例如，加拿大的Theralase Technology公司在抗癌治疗（ACT）和医疗雷射技术（MLT）领域均生产专利雷射技术，并将于2021年宣布推出突破性的新型疼痛和癌症解决方案。该公司还透露，其领先的 PDC 可以消灭多种病毒，包括 H1N1 流感和兹卡。

北美地区的全球市场占有率预计将迅速增加。

北美传统上一直是治疗雷射的主要市场，但全球市场占有率预计将迅速增加。这是由于该地区几个国家对整容手术的需求不断增长。使用雷射治疗进行静脉、表面置换和除毛的主要美容疗程在该地区显着增加。例如，根据美国整形外科医师协会的年度报告，2020年有168,682例雷射静脉治疗、997,245例雷射换肤表面置换、757,808例雷射除毛治疗。因此，这些广泛的医疗应用和这些手术的广泛采用正在推动该地区治疗雷射市场的需求。

此外，对这些雷射的需求不断增长也是由于该地区专利数量的增加。例如，2021 年 7 月，领先的医疗解决方案公司 Aspen Laser LLC 获得了美国专利商标局 (USPTO) 的新专利。据报道，该专利涵盖了该公司製造并在兽医和医疗市场销售的某些雷射设备。

此外，该地区的主要企业正致力于实施合併、合作协议和收购等策略性倡议，以加强其市场地位。例如，2021年9月，波士顿科学公司从BPEA（霸菱亚洲私募股权公司）的关联公司完成了对能源医疗解决方案公司Lumenis LTD的全球外科业务的收购。 Lumenis 的外科业务包括用于耳鼻喉科和泌尿系统手术的光纤、先进雷射系统和配件。此类新兴市场的开拓预计将进一步推动市场成长。

市场的主要发展：

  • 2023 年 6 月 - 牙科雷射领域的全球领导者 BioLASE 与美国顶级非麻醉宠物牙科提供者 Pet Dental Services (PDS) 合作，整合 BIOLASE 的二极体雷射技术。 PDS旨在获得全国兽医的信任和信心，并透过兽医医院提供服务。 PDS 在超过 300 名兽医组成的网路中享有盛誉。 BioLASE的二极体雷射技术不仅可以治疗牙周病，还可以帮助您的宠物过上健康的生活。 BioLASE 的专有雷射产品包含约 266 项取得专利的技术和 25 项正在申请专利的技术，并记录了卓越的生物和临床性能，可减少疼痛并加快恢復速度。
  • 2023 年 4 月 - Lumibird Medical 推出了 Ellex(R) 的两款全新下一代 Nd:YAG/SLT 雷射、Tango(TM) Neo 和 Ultra Q(TM) Reflex Neo。 Tango Reflex(TM) Neo 是一种完全整合的Q 开关Nd:YAG，用于眼前段YAG 和青光眼，采用第二代Reflex(TM) 技术和真正的同轴照明(TCI(TM))，它是一种雷射。它还具有 Imprint(TM)、动态抬头显示器、用于能量设定的操纵桿控制以及用于 PROcap(TM) 的高达 2mm YAG 后偏移 - 高级屈光结果囊切开术。 Tango(TM) Neo 是一个改进的通用使用者介面，具有现代的外观和感觉。
  • 2023 年 4 月 - Topcon Corporation 将与 Espansione Group 合作，在东南亚地区销售该公司的光学技术。透过此次合作，拓普康将推出光调製(R) 低强度光疗法(LM(R) LLLT)、光生物调製技术和最佳功率能量(R) 强脉衝光(OPE(R) IPL) 等创新疗法。这项战略合作关係将使 Espansione 能够突破亚太地区和东南亚眼科护理的界限。拓普康的服务范围已扩大到包括从预测到有效干眼治疗和治疗后追踪的全面解决方案。

目录

第一章简介

  • 市场概况
  • 市场定义
  • 调查范围
  • 市场区隔
  • 货币
  • 先决条件
  • 基准年和预测年时间表
  • 相关利益者的主要利益

第二章调查方法

  • 研究设计
  • 调查过程

第三章执行概述

  • 主要发现

第四章市场动态

  • 市场驱动因素
  • 市场限制因素
  • 波特五力分析
  • 产业价值链分析
  • 分析师观点

第五章治疗雷射的全球市场：依治疗分类

  • 介绍
  • 二氧化碳雷射
  • YAG（钇铝石榴石）雷射器
  • 脉衝染料雷射
  • 氩雷射
  • 低功率雷射治疗 (LLLT)

第六章治疗雷射的全球市场：依应用分类

  • 介绍
  • LASIK或雷射眼科手术
  • 牙齿美白
  • 去除美容疤痕、刺青和皱纹
  • 肿瘤切除
  • 其他的

第七章 全球治疗雷射市场：按地区划分

  • 介绍
  • 北美洲
  • 南美洲
  • 欧洲
  • 中东/非洲
  • 亚太地区

第八章竞争环境及分析

  • 主要企业及策略分析
  • 市场占有率分析
  • 合併、收购、协议和合作
  • 竞争对手仪表板

第九章 公司简介

  • BTL
  • ERCHONIA CORPORATION
  • Theralase（R）Technologies Inc.
  • Cutting Edge Laser Technologies
  • BioFlex Laser Therapy
  • El.En. Group
  • Lynton Lasers Ltd.
  • Fotona doo
  • Capillus, LLC
  • LiteCure, LLC
简介目录
Product Code: KSI061612144

The global therapeutic laser market is expected to grow at a CAGR of 9.47% over the forecast period to reach a total market size of US$237.022 billion by 2029, increasing from US$125.805 billion in 2022.

A therapeutic laser system is a drug-free, non-invasive therapy approach that relieves chronic and acute pain while also improving blood circulation. These devices employ laser pulses that penetrate through the skin without creating warmth, injury, or other negative effects. The therapeutic laser system speeds up wound healing and lowers soft tissue inflammation and discomfort. This laser therapy is viewed as an alternative, if not a supplement, to standard medication and surgical treatment. These laser systems include a long-term therapeutic effect by addressing the fundamental causes of illness disorders.

Therapeutic lasers, also known as low-level lasers or cold lasers, are medical devices that use low-level light to stimulate cellular function and promote healing. They are used in various medical and healthcare applications for pain management, wound healing, and tissue repair. The market includes different types of therapeutic lasers, such as diode lasers, dye lasers, and CO2 lasers. Therapeutic lasers are widely used for pain relief, wound healing, dermatology, and dentistry. Key players in the market include established medical device companies and emerging players.

Regulatory approvals from health authorities like the FDA and EMA are essential for market entry. Restraints include limited awareness among healthcare providers and patients about therapeutic lasers' benefits and reimbursement issues. Future trends include integration with other technologies, home-use devices, and ongoing research and clinical trials. The global therapeutic laser market is expected to expand globally due to increased awareness, technological advancements, and growing demand for non-invasive therapeutic options.

Market Drivers:

  • Increased cancer incidences are anticipated to propel the demand for therapeutic lasers globally.

The need for a therapeutic laser is increasing due to rising cancer occurrences globally, an increase in the number of operations, and increased awareness of self-care and self-management. Furthermore, increased disposable income, rising healthcare spending, and shorter hospital stays would drive the worldwide therapeutic laser market in the projected decade and beyond.

Moreover, several companies have taken the initiative to launch new innovative products that have propelled the market to grow during the projected period. For instance, Theralase Technology, a Canadian producer of patent laser technologies in both the Anti-Cancer Therapy (ACT) and Medical Laser Technology (MLT) sectors, intends to introduce new, breakthrough pain and cancer solutions in 2021. They've also shown that their primary PDC can eliminate several viruses, including H1N1 flu and Zika.

North America region is expected to witness a surge in its global market share.

North America has been a major market for therapeutic lasers until now and is expected to surge in its global market share. This can be attributed to the growing prevalence of demand for cosmetic surgeries across several countries in this region. Primary cosmetic treatments for veins, skin resurfacing, and hair removal using laser therapy have increased significantly in the region. For instance, according to the American Society of Plastic Surgeons annual report, it was reported that 168,682 laser treatments for veins, 997,245 laser skin resurfacing, and 757,808 laser removal procedures were performed in 2020. Thus, these extensive medical applications and the wide adoption of these procedures have propelled the demand for the therapeutic lasers market in the region.

Further, the growing demand for these lasers can also be attributed to an increase in the provision of patents in the region. For instance, in July 2021, Aspen Laser LLC, which is a major medical solutions company, was awarded a new patent by the USPTO (U.S. Patent and Trademark Office). The patent was reported to cover particular laser devices that would be manufactured by the company and sold in the veterinary and medical markets.

Furthermore, major companies in the region have been focused on the implementation of strategic initiatives, such as mergers, collaborative agreements, and acquisitions, for the consolidation of their position in the market. For instance, in September 2021, Boston Scientific completed the acquisition of the worldwide surgical business of Lumenis LTD, an energy-based medical solutions company, from an affiliate of BPEA (Baring Private Equity Asia). The surgical business of Lumenis comprised of fibers, premier laser systems, and accessories that are deployed in the otolaryngology and urology procedures. Thus, developments like these are further expected to propel the market growth.

Market Key Developments:

  • June 2023- BioLASE, a global leader in dental lasers, partnered with Pet Dental Services (PDS), the top non-anesthetic pet dental provider in the country, to integrate BIOLASE's diode laser technology. PDS aims to gain the trust and confidence of veterinarians across the country, providing service through veterinary hospitals. PDS has an excellent reputation among a network of over 300 veterinarians. BioLASE's diode laser technology not only treats periodontal disease but also helps pets live healthier lives BioLASE's proprietary laser products incorporate approximately 266 patented and 25 patent-pending technologies, providing biologically and clinically superior performance with less pain and faster recovery times.
  • April 2023- Lumibird Medical launched two new next-generation Nd:YAG/SLT lasers, the Tango(TM) Neo and Ultra Q(TM) Reflex Neo, by Ellex(R). The Tango Reflex(TM) Neo is a fully integrated Q-switched Nd:YAG laser for anterior-segment YAG and glaucoma indications, featuring second-generation Reflex(TM) technology with True Coaxial Illumination (TCI(TM)). It also includes Imprint(TM), a dynamic heads-up display, joystick control of energy settings, and up to 2 mm YAG posterior offset for PROcap(TM) - Premium Refractive Outcome Capsulotomies. The Tango(TM) Neo has an improved general user interface with a modern look and feel. The lasers are CE-marked and USA FDA 510K approved.
  • April 2023- Topcon Corporation partnered with Espansione Group to distribute their light-based technologies in the Southeast Asian region. The partnership allows Topcon to access innovative treatment products like Light Modulation(R) Low-level Light Therapy (LM(R) LLLT), photobiomodulation technology, and Optimal Power Energy(R) Intense Pulsed Light (OPE(R) IPL). This strategic alliance enables Espansione to push the boundaries of ophthalmology in APAC and SEA. Topcon's service spectrum expand, offering comprehensive solutions from pre-diagnosis to effective dry eye treatment and post-treatment follow-ups.

Market Segmentation:

By Therapy

  • Carbon Dioxide Laser
  • YAG (yttrium aluminum garnet) Laser
  • Pulsed Dye Laser
  • Argon Laser
  • Low-level laser therapy (LLLT)

By Application

  • LASIK or Laser Eye Surgery
  • Teeth Whitening
  • Cosmetic Scar, Tattoo or Wrinkle Removal
  • Tumor Removal
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • United Kingdom
  • Spain
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Thailand
  • Others

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. Market Overview
  • 1.2. Market Definition
  • 1.3. Scope of the Study
  • 1.4. Market Segmentation
  • 1.5. Currency
  • 1.6. Assumptions
  • 1.7. Base and Forecast Years Timeline
  • 1.8. Key Benefits to the Stakeholder

2. RESEARCH METHODOLOGY

  • 2.1. Research Design
  • 2.2. Research Processes

3. EXECUTIVE SUMMARY

  • 3.1. Key Findings

4. MARKET DYNAMICS

  • 4.1. Market Drivers
  • 4.2. Market Restraints
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers
    • 4.3.2. Bargaining Power of Buyers
    • 4.3.3. Threat of New Entrants
    • 4.3.4. Threat of Substitutes
    • 4.3.5. Competitive Rivalry in the Industry
  • 4.4. Industry Value Chain Analysis
  • 4.5. Analyst View

5. GLOBAL THERAPEUTIC LASER MARKET BY THERAPY

  • 5.1. Introduction
  • 5.2. Carbon Dioxide Laser
    • 5.2.1. Market Opportunities and Trends
    • 5.2.2. Growth Prospects
    • 5.2.3. Geographic Lucrativeness
  • 5.3. YAG (yttrium aluminum garnet) Laser
    • 5.3.1. Market Opportunities and Trends
    • 5.3.2. Growth Prospects
    • 5.3.3. Geographic Lucrativeness
  • 5.4. Pulsed Dye Laser
    • 5.4.1. Market Opportunities and Trends
    • 5.4.2. Growth Prospects
    • 5.4.3. Geographic Lucrativeness
  • 5.5. Argon Laser
    • 5.5.1. Market Opportunities and Trends
    • 5.5.2. Growth Prospects
    • 5.5.3. Geographic Lucrativeness
  • 5.6. Low-level laser therapy (LLLT)
    • 5.6.1. Market Opportunities and Trends
    • 5.6.2. Growth Prospects
    • 5.6.3. Geographic Lucrativeness

6. GLOBAL THERAPEUTIC LASER MARKET BY APPLICATION

  • 6.1. Introduction
  • 6.2. LASIK or Laser Eye Surgery
    • 6.2.1. Market Opportunities and Trends
    • 6.2.2. Growth Prospects
    • 6.2.3. Geographic Lucrativeness
  • 6.3. Teeth Whitening
    • 6.3.1. Market Opportunities and Trends
    • 6.3.2. Growth Prospects
    • 6.3.3. Geographic Lucrativeness
  • 6.4. Cosmetic Scar, Tattoo or Wrinkle Removal
    • 6.4.1. Market Opportunities and Trends
    • 6.4.2. Growth Prospects
    • 6.4.3. Geographic Lucrativeness
  • 6.5. Tumor Removal
    • 6.5.1. Market Opportunities and Trends
    • 6.5.2. Growth Prospects
    • 6.5.3. Geographic Lucrativeness
  • 6.6. Others
    • 6.6.1. Market Opportunities and Trends
    • 6.6.2. Growth Prospects
    • 6.6.3. Geographic Lucrativeness

7. GLOBAL THERAPEUTIC LASER MARKET BY GEOGRAPHY

  • 7.1. Introduction
  • 7.2. North America
    • 7.2.1. By Therapy
    • 7.2.2. By Application
    • 7.2.3. By Country
      • 7.2.3.1. USA
        • 7.2.3.1.1. Market Opportunities and Trends
        • 7.2.3.1.2. Growth Prospects
      • 7.2.3.2. Canada
        • 7.2.3.2.1. Market Opportunities and Trends
        • 7.2.3.2.2. Growth Prospects
      • 7.2.3.3. Mexico
        • 7.2.3.3.1. Market Opportunities and Trends
        • 7.2.3.3.2. Growth Prospects
  • 7.3. South America
    • 7.3.1. By Therapy
    • 7.3.2. By Application
    • 7.3.3. By Country
      • 7.3.3.1. Brazil
        • 7.3.3.1.1. Market Opportunities and Trends
        • 7.3.3.1.2. Growth Prospects
      • 7.3.3.2. Argentina
        • 7.3.3.2.1. Market Opportunities and Trends
        • 7.3.3.2.2. Growth Prospects
      • 7.3.3.3. Others
        • 7.3.3.3.1. Market Opportunities and Trends
        • 7.3.3.3.2. Growth Prospects
  • 7.4. Europe
    • 7.4.1. By Therapy
    • 7.4.2. By Application
    • 7.4.3. By Country
      • 7.4.3.1. Germany
        • 7.4.3.1.1. Market Opportunities and Trends
        • 7.4.3.1.2. Growth Prospects
      • 7.4.3.2. France
        • 7.4.3.2.1. Market Opportunities and Trends
        • 7.4.3.2.2. Growth Prospects
      • 7.4.3.3. United Kingdom
        • 7.4.3.3.1. Market Opportunities and Trends
        • 7.4.3.3.2. Growth Prospects
      • 7.4.3.4. Spain
        • 7.4.3.4.1. Market Opportunities and Trends
        • 7.4.3.4.2. Growth Prospects
      • 7.4.3.5. Others
        • 7.4.3.5.1. Market Opportunities and Trends
        • 7.4.3.5.2. Growth Prospects
  • 7.5. Middle East and Africa
    • 7.5.1. By Therapy
    • 7.5.2. By Application
    • 7.5.3. By Country
      • 7.5.3.1. Saudi Arabia
        • 7.5.3.1.1. Market Opportunities and Trends
        • 7.5.3.1.2. Growth Prospects
      • 7.5.3.2. UAE
        • 7.5.3.2.1. Market Opportunities and Trends
        • 7.5.3.2.2. Growth Prospects
      • 7.5.3.3. Others
        • 7.5.3.3.1. Market Opportunities and Trends
        • 7.5.3.3.2. Growth Prospects
  • 7.6. Asia Pacific
    • 7.6.1. By Therapy
    • 7.6.2. By Application
    • 7.6.3. By Country
      • 7.6.3.1. China
        • 7.6.3.1.1. Market Opportunities and Trends
        • 7.6.3.1.2. Growth Prospects
      • 7.6.3.2. Japan
        • 7.6.3.2.1. Market Opportunities and Trends
        • 7.6.3.2.2. Growth Prospects
      • 7.6.3.3. South Korea
        • 7.6.3.3.1. Market Opportunities and Trends
        • 7.6.3.3.2. Growth Prospects
      • 7.6.3.4. India
        • 7.6.3.4.1. Market Opportunities and Trends
        • 7.6.3.4.2. Growth Prospects
      • 7.6.3.5. Thailand
        • 7.6.3.5.1. Market Opportunities and Trends
        • 7.6.3.5.2. Growth Prospects
      • 7.6.3.6. Others
        • 7.6.3.6.1. Market Opportunities and Trends
        • 7.6.3.6.2. Growth Prospects

8. COMPETITIVE ENVIRONMENT AND ANALYSIS

  • 8.1. Major Players and Strategy Analysis
  • 8.2. Market Share Analysis
  • 8.3. Mergers, Acquisitions, Agreements, and Collaborations
  • 8.4. Competitive Dashboard

9. COMPANY PROFILES

  • 9.1. BTL
  • 9.2. ERCHONIA CORPORATION
  • 9.3. Theralase(R) Technologies Inc.
  • 9.4. Cutting Edge Laser Technologies
  • 9.5. BioFlex Laser Therapy
  • 9.6. El.En. Group
  • 9.7. Lynton Lasers Ltd.
  • 9.8. Fotona d.o.o.
  • 9.9. Capillus, LLC
  • 9.10. LiteCure, LLC